Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-07 4:17 pm Purchase | 2026-03-31 | 13G | VIPSHOP HLDGS LTD SPONSORED AD VIPS | UBS Group AG | 16,129,947 20.000% | 186,677![]() (+1.17%) | Filing History |
| 2026-05-07 4:06 pm Sale | 2026-03-31 | 13G | WESTERN ASSET INVESTMENT GRADE IGI | UBS Group AG | 0 0.000% | -345,414![]() (Position Closed) | Filing History |
| 2026-05-07 12:56 pm Purchase | 2026-03-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | UBS Group AG | 746,095 5.800% | 746,095![]() (New Position) | Filing History |
| 2026-05-07 11:56 am Purchase | 2026-03-31 | 13G | APEX TECH ACQUISITION INC USD TRADU | UBS Group AG | 762,688 5.400% | 762,688![]() (New Position) | Filing History |
| 2026-05-07 11:28 am Purchase | 2026-03-31 | 13G | AMICUS THERAPEUTICS INC FOLD | UBS Group AG | 17,141,817 5.500% | 17,141,817![]() (New Position) | Filing History |
| 2026-05-01 09:41 am Sale | 2026-03-31 | 13G | ABRDN INCOME CREDIT STRATEGIES ACPPRA | UBS Group AG | 531,368 33.200% | -26,878![]() (-4.81%) | Filing History |
| 2026-01-30 2:09 pm Purchase | 2025-12-31 | 13G | NUVEEN CALIF MUN VALUE FUND NCA | UBS Group AG | 1,792,995 5.400% | 1,792,995![]() (New Position) | Filing History |
| 2026-01-30 2:00 pm Purchase | 2025-12-31 | 13G | AMC ENTMT HLDGS INC AMC | UBS Group AG | 31,798,761 6.200% | 31,798,761![]() (New Position) | Filing History |
| 2026-01-07 10:30 am Sale | 2025-12-31 | 13G | ABRDN INCOME CREDIT STRATEGIES ACPPRA | UBS Group AG | 558,246 34.900% | -91,605![]() (-14.10%) | Filing History |
| 2025-10-24 1:05 pm Sale | 2025-09-30 | 13G | ABRDN INCOME CREDIT STRATEGIES ACPPRA | UBS Group AG | 649,851 40.600% | -33,006![]() (-4.83%) | Filing History |
| 2025-07-29 1:39 pm Sale | 2025-06-30 | 13G | ABRDN INCOME CREDIT STRATEGIES ACPPRA | UBS Group AG | 682,857 42.700% | -25,911![]() (-3.66%) | Filing History |
| 2025-07-29 1:01 pm Sale | 2025-06-30 | 13G | RAPID7 INC RPD | UBS Group AG | 0 0.000% | -3,345,168![]() (Position Closed) | Filing History |
| 2025-05-01 06:24 am Sale | 2025-03-31 | 13G | RAPID7 INC RPD | UBS Group AG | 3,345,168 5.200% | -596,369![]() (-15.13%) | Filing History |
| 2025-04-30 4:41 pm Unchanged | 2025-03-31 | 13G | RENALYTIX PLC ADS RNLXY | UBS Group AG | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-04-30 4:15 pm Sale | 2024-12-31 | 13G | RENALYTIX PLC ADS RNLXY | UBS Group AG | 0 0.000% | -16,774,708![]() (Position Closed) | Filing History |
| 2025-04-30 3:52 pm Sale | 2025-03-31 | 13G | PIMCO ACCESS INCOME FD COM PAXS | UBS Group AG | 0 0.000% | -2,233,985![]() (Position Closed) | Filing History |
| 2025-04-30 3:48 pm Sale | 2025-03-31 | 13G | COLOR STAR TECHNOLOGY CO LTD ADD | UBS Group AG | 0 0.000% | -1,486![]() (Position Closed) | Filing History |
| 2025-04-30 3:31 pm Purchase | 2025-03-31 | 13G | WESTERN ASSET INVESTMENT GRADE IGI | UBS Group AG | 345,414 5.800% | 345,414![]() (New Position) | Filing History |
| 2025-04-30 2:46 pm Sale | 2025-03-31 | 13G | ABRDN INCOME CREDIT STRATEGIES ACPPRA | UBS Group AG | 708,768 44.300% | -41,551![]() (-5.54%) | Filing History |
| 2025-04-30 11:44 am Sale | 2025-03-31 | 13G | INFINERA CORPORATION INFN | UBS Group AG | 0 0.000% | -14,484,028![]() (Position Closed) | Filing History |

